Genmab reported DKK4.96B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Almirall EUR 303.77M 21.04M Jun/2026
Amgen USD 51.61B 250M Sep/2026
argenx SE USD 36M 432K Jun/2026
AstraZeneca USD 28.8B 2.79B Sep/2026
Bayer EUR 37.7B 6.54B Sep/2026
BioMarin Pharmaceutical USD 3.51B 12.96M Sep/2026
Demant DKK 13.13B 5.86B Jun/2026
Fresenius Medical Care EUR 5.15B 676.78M Sep/2026
Genmab DKK 4.96B 28M Jun/2026
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
GN Store Nord DKK 7.72B 394M Sep/2026
GRIFOLS EUR 8.69B 1.52B Sep/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Insmed USD 544.86M 1.35M Sep/2026
Lakefront Biotherapeutics EUR 1.83M 2.94M Sep/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.34B 866M Sep/2026
Novartis USD 38.38B 893M Sep/2026
Regeneron Pharmaceuticals USD 1.99B 400K Sep/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 16.28B 1.63B Sep/2026
UCB EUR 2.18B 634M Dec/2025